[ Pioneering Genomic Innovation Since 2022 ]

Decoding the Human Blueprint — One Gene at a Time

Transforming healthcare through precision genomics, AI-powered insights, and personalized medicine.

[ Founded 2022 ][ 50+ Experts ][ 6+ Countries ][ 10,000+ Tests Delivered ]

Who We Are

The Gene Matrix team at their Chicago Fulton Market headquarters
Who We Are

Pioneering Genomics

GeneMatrix is a pioneering genomics company dedicated to making personalized medicine accessible to everyone. Through cutting-edge DNA analysis and AI-powered insights, we're transforming healthcare one genome at a time.

Our Mission

Democratize Precision Medicine

To democratize precision medicine by providing accurate, affordable, and actionable genetic insights that empower individuals and healthcare providers to make informed decisions about health and wellness.

Our Vision

A Genetic Blueprint For All

A world where every person has access to their genetic blueprint, enabling proactive healthcare, disease prevention, and optimized wellness through the power of genomic science.

Our Story

[ From A Single Lab To A Global Genomics Leader ]
2022

The Beginning: A Vision Born in Science

GeneMatrix was founded in 2022 by Tarek Younis — a healthcare technology entrepreneur united by one conviction: that every person deserves access to the power of their own genetic blueprint. From our Chicago headquarters, we set out to bridge the gap between cutting-edge genomic science and real-world clinical care.

Democratizing precision medicine from day one.
2022

First CLIA-Certified Lab Opens

In 2022, GeneMatrix opened its first fully CLIA-certified, CE-IVD Certified laboratory — a state-of-the-art facility engineered for high-throughput genomic sequencing. This milestone allowed us to scale from research to real clinical delivery, processing thousands of samples with 99.9% accuracy (validated against Sanger sequencing with 100% concordance per CAP proficiency testing) and industry-leading turnaround times.

99.9% accuracy, CAP-validated. Clinical-grade from the start.
2024

AI Revolution: AI-Powered Genomic Intelligence

In 2024, we integrated our proprietary AI engine — trained on millions of anonymized genetic profiles — directly into our diagnostic pipeline. This leap transformed raw sequencing data into actionable, personalized health insights in real time, enabling clinicians and patients to make faster, smarter decisions backed by genomic science.

Real-time AI interpretation. Personalized at scale.
2025

Global Reach: EU & Balkan Expansion

Today, GeneMatrix operates across 6 countries with a focused expansion into the European Union and Balkan Regions — bringing precision genomics to underserved healthcare markets. Our global network of certified lab partners and clinical affiliates ensures that world-class genetic testing is accessible regardless of geography.

EU & Balkans — precision medicine without borders.

Mission & Vision

[ Guided By Purpose, Driven By Innovation ]
Mission

Guided by Purpose

To democratize precision genomics by making advanced genetic testing accessible, affordable, and actionable for everyone, empowering individuals to take control of their health through personalized insights. Accessible genetic testing for all · AI-powered personalized insights · Evidence-based recommendations · Privacy-first approach.

Vision

Driven by Innovation

A world where every individual has access to their genetic blueprint, enabling proactive healthcare decisions that prevent disease, optimize wellness, and extend healthy lifespan through precision medicine. Global healthcare transformation · Preventive medicine revolution · Personalized treatment plans · Extended healthy lifespan.

Core Values

[ The Principles That Power Everything We Do ]
Trust & Privacy

Security First

Your genetic data is protected with military-grade encryption and zero-knowledge architecture. We never share, sell, or access your data without explicit consent. — AES Encryption

Scientific Excellence

Built On Science. Driven By Purpose.

Every test is validated through peer-reviewed research and certified by our team of world-class geneticists, ensuring the highest accuracy in every result. — Accuracy Rate

Patient-Centered Care

Human First

We place individuals at the heart of every decision — delivering actionable, personalized insights that empower proactive health management and informed choices. — Patients Helped

Global Accessibility

Precision Medicine Without Borders

Breaking down barriers to make precision genetic healthcare available and affordable to communities across the EU, Balkans, and beyond — no matter where you are. — Countries Served

AI-Driven Innovation

Next-Gen AI

Continuously advancing genetic testing through proprietary AI models, deep learning, and cutting-edge research — pushing the boundaries of what genomics can achieve. — AI Integration

Collaborative Impact

Partner Networks

Partnering with healthcare providers, research institutions, and global communities to co-create solutions that drive measurable improvements in health outcomes.

Our Journey

[ Milestones That Define Us ]
2017

Foundation

GeneMatrix was founded with a vision to democratize personalized healthcare through genetic testing.

2022

First Lab Opening

Opened our state-of-the-art genetic testing laboratory with CLIA and CAP certifications.

2024

AI Integration

Launched our proprietary AI engine for advanced genetic data analysis and personalized recommendations.

2025

Global Expansion

Expanded operations across the EU and Balkan Regions, bringing personalized genetic healthcare to new communities.

2025

10,000 Tests Milestone

Surpassed 10,000 genetic tests processed, helping families across 6 countries make informed health decisions.

2025

Innovation Hub

Established our newest Fulton Labs Headquarters, a cutting-edge R&D Innovation Center focusing on next-generation genetic testing technologies.

Meet Our Leadership

[ Decades Of Industry Expertise ]
Founder & CEO

Tarek Younis — Chief Executive Officer

Tarek Younis is the visionary founder and CEO of Gene Matrix AI, leading the company's mission to revolutionize healthcare through AI-powered genetic diagnostics. With over 15 years of experience in healthcare technology and biotechnology, Tarek has been instrumental in bridging the gap between advanced genomic science and accessible healthcare solutions. Healthcare Innovation · AI & Genomics · Strategic Leadership.

Chief Scientific Officer

Dr. James Chen

Dr. Chen leads our scientific research and development initiatives, bringing 20+ years of experience in molecular genetics and computational biology from Stanford University and leading biotech firms. Molecular Genetics · Computational Biology · Research Leadership.

Executive Director of Business & Operations

Lammy Shaheen

Lammy Shaheen oversees business strategy and operational excellence at Gene Matrix AI. With extensive experience in healthcare operations and business development, she ensures seamless execution of our mission to deliver world-class genetic testing services. Business Strategy · Operations Management · Healthcare Leadership.

Regional Director Of MENA

Raneem Hamadeh

Raneem leads Gene Matrix's strategic initiatives across the Middle East and North Africa, building high-impact partnerships with healthcare systems and government agencies. Her deep understanding of regional markets and regulatory landscapes accelerates access to precision genomics for millions. MENA Markets · Strategic Partnerships · Regional Expansion.

Chief Medical Officer

Dr. Michael Okonkwo

Dr. Okonkwo ensures clinical excellence across all testing services. Board-certified in medical genetics with fellowship training at Johns Hopkins, he oversees our medical advisory board and clinical protocols. Medical Genetics · Clinical Protocols · Healthcare Quality.

Laboratory Director, CLIA

Shawn Desai

Board-certified laboratory director overseeing all clinical operations under CLIA ID 14D2276402. Holds MD/PhD credentials with fellowship training in clinical pathology and molecular genetics. Responsible for next-generation sequencing protocols, quality assurance, regulatory compliance, and maintaining 99.9% test accuracy across all genetic panels. Clinical Pathology · NGS Sequencing · Quality Assurance · Regulatory Compliance.

Director of African Markets

Dr. Amara Nkosi

Dr. Nkosi leads our mission to bring precision medicine to Africa. With a PhD in Public Health from Harvard and deep expertise in healthcare systems across the continent, she drives impactful partnerships. Public Health · African Healthcare.

Medical Advisory Board

[ Board-Certified Experts Behind Every Result ]
ABMGGCertified
WHOConsultants
4Specialties
120+Yrs Combined Exp.
Medical Genetics Advisor — ABMGG Board Certified

Dr. Sarah Goldstein — MD, PhD, FACMG

Northwestern University Feinberg School of Medicine. Specialty: Clinical Genetics & Genomics. Focus: Hereditary cancer syndromes, BRCA variant interpretation, and genetic counseling protocols.

Pharmacogenomics Advisor — CPIP Certified

Dr. Rajiv Mehta — PharmD, PhD

University of Chicago Pritzker School of Medicine. Specialty: Pharmacogenomics & Drug Safety. Focus: PGx-guided prescribing, CYP450 enzyme polymorphisms, and adverse drug reaction prevention.

Reproductive Genetics Advisor — ABOG Board Certified

Dr. Elena Vasquez — MD, MS, FACOG

Rush University Medical Center. Specialty: Reproductive & Prenatal Genetics. Focus: Carrier screening, preimplantation genetic testing, and fetal genomic diagnostics.

Cardiovascular Genetics Advisor — ACC Fellow

Dr. Marcus Webb — MD, FACP, FAHA

Loyola University Medical Center. Specialty: Cardiovascular Genomics. Focus: Familial hypercholesterolemia, inherited arrhythmias, and cardiac risk stratification via genomics.

Bioinformatics & AI Advisor — EMBL-EBI Fellow

Dr. Ingrid Larsson — PhD, MSc

European Bioinformatics Institute (EMBL-EBI). Specialty: Computational Genomics & AI. Focus: Variant classification algorithms, polygenic risk scoring, and AI-driven genomic interpretation pipelines.

Global Health & Equity Advisor — WHO Consultant

Dr. Kwame Asante — MD, MPH, FACP

Johns Hopkins Bloomberg School of Public Health. Specialty: Global Health Genomics. Focus: Genomic equity in underserved populations, African ancestry variant databases, and community health integration.

Independent clinical oversight — our advisory board reviews test methodologies, variant classifications, and clinical report standards on a quarterly basis.

Verified Credentials

[ Lab Certifications & Media Coverage ]
CLIA Certified — CLIA ID: 14D2276402

Centers for Medicare & Medicaid Services (CMS)

Clinical Laboratory Improvement Amendments — the federal standard for laboratory quality and accuracy.

NPI Verified — NPI #1225729312

NPPES NPI Registry — U.S. Department of Health & Human Services

National Provider Identifier (NPI) is the standard unique health identifier for covered health care providers, issued by the federal NPPES registry.

HIPAA Compliant — Verified Compliance

U.S. Department of Health & Human Services

Full compliance with the Health Insurance Portability and Accountability Act for patient data privacy and security.

CE-IVD Certified — CE Mark

European Commission

Confirms our diagnostic tests meet EU safety, quality, and performance requirements under the IVDR framework.

ISO 15189 — Accredited Laboratory

International Organization for Standardization

International standard for medical laboratory quality and competence — the highest global benchmark for diagnostic labs.

NBC Chicago — Community Impact

“Genomics Lab Helps Open Doors for Trust and Inclusivity”

NBC Chicago covers how Gene Matrix is working to build trust in genetic testing among underserved communities of color in the Chicago area.

Read the original article ↗

NBC Chicago — Lab Feature

“Bedord Park Lab Serves Needs of Local Communities of Color”

NBC Chicago features Gene Matrix's Bedford Park laboratory and its mission to make precision genetic testing accessible to diverse communities.

Watch the original feature ↗

We do not list hospital or institutional partnerships unless a formal, signed agreement is in place. The media coverage above links directly to published articles on the original news outlets.

Start Your Genetic Health Journey

[ Ready To Experience The Difference? ]
Gene Matrix Membership$89/mo

All 11 Tests Included · $59/mo Billed Annually ($712/yr) · 48-Hour Priority Results · Genetic Counselor Session

All tests include a DNA kit, AI-powered analysis, and lifetime access to your HIPAA-secure portal. HSA/FSA eligible · Cancel anytime · 5–7 day results

Ready to Unlock Your Genetic Potential?

Join 10,000+ patients who trust GeneMatrix for precision genomic insights.

[ 10,000+ Tests Completed ][ 99.9% Validated vs Sanger Sequencing ][ 24/7 Support Available ]